The Colorectal & Peritoneal Oncology Centre, The Christie Hospital NHS Foundation Trust, Manchester
Malcolm has been a Consultant Colorectal and Peritoneal Oncology Surgeon at the Christie Hospital NHS Foundation Trust since 2000. Having been Clinical Director for Surgery, Christie Hospital from 2006-2014 and Lead Clinician for Colorectal Cancer, Christie Hospital from 2016-2018, he has been the Joint Lead of the Peritoneal Tumour Service, Christie Hospital since 2002. Malcolm am a Senior Lecturer at the Dept of Medicine, University of Manchester. His unit was awarded Cancer Care Team of the year at the BMJ Awards in 2013 for its work in the care of patients with colorectal peritoneal metastases.
Cytoreduction and HIPEC in the treatment of peritoneal disease from appendiceal and colorectal tumours
The aim will be to give an overview in the management of peritoneal disease from both appendiceal and colorectal tumours. This will pay particular attention to the use of cytoreductive surgery and heated intra-peritoneal chemotherapy (HIPEC) and will draw on my unit’s experience of being one of the National Centres in the UK that treats this. We have performed over 1250 cases over the last 18 years and now perform 155-160 cases per year.
EVEN MORE SEMINARS
Mr Richard Steyn UK Lung Cancer Coalition / University Hospitals Birmingham NHS Foundation Trust
Doubling Five-Year UK Lung Cancer Survival to 25% by 2025
Dr Sileida Oliveros GenesisCare
Surface-Guided Radiotherapy and Optimal Breast Cancer Treatment
Hamed Javan MD Jewish General Hospital
Systemic Cancer Therapy: Pancreatic and Colorectal Cancer – Pre-operative FOLFIRINOX in pancreatic cancer
AGSM, PgDipRNCM, RGN Cancer Hopeline
Empowering Cancer Patients to Optimal Treatment Outcomes and Prognosis
Professor Hisham Mehanna InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham
Clinical trials that change patient care and the lessons learnt